Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motoshi Ichikawa

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 4, 2023
[Current state of treatment for myelodysplastic syndromes]Motoshi Ichikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 2025
[Management of MDS according to risk classifications]Motoshi Ichikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Management of lower-risk myelodysplastic syndromes]Motoshi Ichikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 2, 2022
[Updated treatment strategies for myelodysplastic syndromes]Motoshi Ichikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
Pathophysiology of MDS: genomic aberrationsMotoshi Ichikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Molecular mechanisms in the development of acute myeloid leukemia]Motoshi Ichikawa, Mineo Kurokawa
Critical Reviews in Immunology|March 8, 2007
Structure and function of cas-L and integrin-mediated signalingSachiko Seo, Motoshi Ichikawa, Mineo Kurokawa
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2013
Serial profile of vitamins and trace elements during the acute phase of allogeneic stem cell transplantationYasuhito Nannya, Akihito Shinohara, Motoshi Ichikawa, et al.
International Journal of Clinical and Experimental Pathology|December 14, 2012
Acute myeloid leukemia with cryptic CBFB-MYH11 type DTakashi Kobayashi, Motoshi Ichikawa, Yasuhiko Kamikubo, et al.
Japanese Journal of Clinical Oncology|August 20, 2013
The effect of decreased-dose idarubicin for elderly patients with acute myeloid leukemiaTakashi Kobayashi, Motoshi Ichikawa, Yasuhito Nannya, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 4, 2023
[Current state of treatment for myelodysplastic syndromes]Motoshi Ichikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 2025
[Management of MDS according to risk classifications]Motoshi Ichikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Management of lower-risk myelodysplastic syndromes]Motoshi Ichikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 2, 2022
[Updated treatment strategies for myelodysplastic syndromes]Motoshi Ichikawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
Pathophysiology of MDS: genomic aberrationsMotoshi Ichikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Molecular mechanisms in the development of acute myeloid leukemia]Motoshi Ichikawa, Mineo Kurokawa
Critical Reviews in Immunology|March 8, 2007
Structure and function of cas-L and integrin-mediated signalingSachiko Seo, Motoshi Ichikawa, Mineo Kurokawa
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2013
Serial profile of vitamins and trace elements during the acute phase of allogeneic stem cell transplantationYasuhito Nannya, Akihito Shinohara, Motoshi Ichikawa, et al.
International Journal of Clinical and Experimental Pathology|December 14, 2012
Acute myeloid leukemia with cryptic CBFB-MYH11 type DTakashi Kobayashi, Motoshi Ichikawa, Yasuhiko Kamikubo, et al.
Japanese Journal of Clinical Oncology|August 20, 2013
The effect of decreased-dose idarubicin for elderly patients with acute myeloid leukemiaTakashi Kobayashi, Motoshi Ichikawa, Yasuhito Nannya, et al.
Pageof 10